| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.18B | -2.5% |
| Gross profit | ¥0.08B | — |
| Operating income | ¥-0.00B | — |
| Net income | ¥-0.00B | -107.3% |
| Gross margin | 44.6% | Net margin -0.6% |
| Revenue Q/Q | -47.4% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.10B | 55.4% |
| R&D | ¥0.02B | 13.2% |
| SG&A | ¥0.05B | 29.6% |
| Tax & other | ¥-0.00B | -0.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
天和防务 ・ 飞凯材料 ・ 天利科技 ・ 劲拓股份 ・ 花园生物 ・ 宝色股份 ・ 汉宇集团 ・ 博济医药 ・ 科隆股份 ・ 九强生物 ・ 凯发电气 ・ 道氏技术
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies